Tirzepatide Compositions And Use

Abstract: A composition and methods of dosing such tirzepatide composition, comprising a tirzepatide, or a salt thereof at a concentration selected from the group consisting of 2.5 mg/mL, 40 mg/mL, and 50 mg/mL; NaCl; and dibasic sodium phosphate is provided.

Patent Information

Application #

Filing Date

27 December 2024

Publication Number

2/2025

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

Parent Application

Applicants

ELI LILLY AND COMPANY

Lilly Corporate center Indianapolis, Indiana 46206-6288

Inventors

1. KOENIG, Michael J.

c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288

2. QIAN, Ken Kangyi

c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis, Indiana 46206-6288

Specification

Documents

Application Documents

#	Name	Date
1	202417103561-STATEMENT OF UNDERTAKING (FORM 3) [27-12-2024(online)].pdf	2024-12-27
2	202417103561-Sequence Listing in txt [27-12-2024(online)].txt	2024-12-27
3	202417103561-Sequence Listing in PDF [27-12-2024(online)].pdf	2024-12-27
4	202417103561-REQUEST FOR EXAMINATION (FORM-18) [27-12-2024(online)].pdf	2024-12-27
5	202417103561-PRIORITY DOCUMENTS [27-12-2024(online)].pdf	2024-12-27
6	202417103561-POWER OF AUTHORITY [27-12-2024(online)].pdf	2024-12-27
7	202417103561-FORM 18 [27-12-2024(online)].pdf	2024-12-27
8	202417103561-FORM 1 [27-12-2024(online)].pdf	2024-12-27
9	202417103561-DECLARATION OF INVENTORSHIP (FORM 5) [27-12-2024(online)].pdf	2024-12-27
10	202417103561-COMPLETE SPECIFICATION [27-12-2024(online)].pdf	2024-12-27
11	202417103561-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [27-12-2024(online)].pdf	2024-12-27
12	202417103561-Proof of Right [09-06-2025(online)].pdf	2025-06-09
13	202417103561-FORM 3 [09-06-2025(online)].pdf	2025-06-09